AURORA CANNABIS (CA), a company active in the Pharmaceuticals industry, slightly increases its general evaluation. The independent financial analyst theScreener just confirmed the stock market behaviour of the title as risky. At the fundamental level, theScreener confirms the rating of 1 out of 4 stars; given the more favourable environment, the title's overall rating is upgraded to Slightly Negative even if it remains under pressure. As of the analysis date March 1, 2022, the closing price was ...
AURORA CANNABIS - SELL | CAD4 VS. CAD10 (-57%) Great medicinal business but poor in recreational Flattish revenues does not impress Profitability remains poor International development mainly geared to medicinal cannabis and CBD
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Aurora Cannabis Closes Previously Announced Bought Deal Financing Over-Allotment Option Exercised in Full EDMONTON, Alberta, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the e...
Aurora Cannabis Inc. Announces US$125 Million Bought Deal Financing EDMONTON, Alberta, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (“Aurora” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets and ATB Capital Markets, under which the underwriters have agreed to buy on bought deal basis 12,000,000 units of the Company (the “Units”), at a price of US$10.45 per Unit for gross proceeds of approximately US$125 million (the “Offering”). Each Unit will be comprised of one common share of the Company (...
Aurora Cannabis Closes Previously Announced Upsized Underwritten Public Offering Over-Allotment Option Exercised in Full EDMONTON, Alberta, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced overnight marketed public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$172,500,000. The Company sold 23,000,000 Units at a price of US$7.50 per Unit, including 3,000,000 Units s...
Aurora Cannabis Prices US$150 Million Underwritten Public Offering EDMONTON, Alberta, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the pricing of its previously announced overnight marketed public offering (the “Offering”) of units of the Company (the “Units”) at a price of US$7.50 per Unit. The underwriters for the Offering have agreed to purchase 20,000,000 Units from the Company for total gross proceeds to the Company of US$150,000,000. Each Unit...
Aurora Cannabis Announces Proposed Public Offering EDMONTON, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it will be filing a preliminary prospectus supplement (the “Preliminary Supplement”) to its short form base shelf prospectus dated October 28, 2020 (the “Base Shelf Prospectus”) relating to a proposed overnight marketed public offering (the “Offering”) of units of the Company (the “Units”) at a price of US$7.50 per Unit for total gr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.